Purple Biotech Ltd.
NASDAQ:PPBT
2.97 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Purple Biotech Ltd. |
Symbool | PPBT |
Munteenheid | USD |
Prijs | 2.97 |
Beurswaarde | 5,721,589 |
Dividendpercentage | 0% |
52-weken bereik | 2.87 - 25.8 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Isaac Israel |
Website | https://purple-biotech.com |
An error occurred while fetching data.
Over Purple Biotech Ltd.
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)